Minimal Residual Disease and Chimerism Analysis Using Circulating Cell-Free DNA After Allogeneic Hematopoietic Cell Transplantation

被引:0
|
作者
Pennisi, Sandra [1 ]
Waterhouse, Miguel [1 ]
Pfeifer, Dietmar [1 ]
Duyster, Justus [1 ]
Bertz, Hartmut [1 ]
Finke, Juergen [1 ]
Duque-Afonso, Jesus [1 ]
机构
[1] Univ Freiburg, Med Ctr, Freiburg, Germany
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
O117
引用
收藏
页码:126 / 128
页数:3
相关论文
共 50 条
  • [1] Cell-free DNA characteristics and chimerism analysis in patients after allogeneic cell transplantation
    Duque-Afonso, Jesus
    Waterhouse, Miguel
    Pfeifer, Dietmar
    Follo, Marie
    Duyster, Justus
    Bertz, Hartmut
    Finke, Juergen
    CLINICAL BIOCHEMISTRY, 2018, 52 : 137 - 141
  • [2] Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation
    Waterhouse, Miguel
    Pennisi, Sandra
    Pfeifer, Dietmar
    Scherer, Florian
    Zeiser, Robert
    Duyster, Justus
    Bertz, Hartmut
    Finke, Juergen
    Duque-Afonso, Jesus
    CANCERS, 2022, 14 (14)
  • [3] CD34+chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation
    Unnikrishnan, Athira
    Meacham, Amy M.
    Goldstein, Steven S.
    Ta, Mai
    Leather, Helen L.
    Cogle, Christopher R.
    Castillo, Paul
    Wingard, John R.
    Norkin, Maxim
    LEUKEMIA RESEARCH, 2018, 74 : 110 - 112
  • [4] Droplet digital PCR for the simultaneous analysis of minimal residual disease and hematopoietic chimerism after allogeneic cell transplantation
    Waterhouse, Miguel
    Pfeifer, Dietmar
    Duque-Afonso, Jesus
    Follo, Marie
    Duyster, Justus
    Depner, Melanie
    Bertz, Hartmut
    Finke, Juergen
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2019, 57 (05) : 641 - 647
  • [5] Chimerism analysis of cell-free DNA in patients treated with allogeneic cell transplantation
    Waterhouse, M.
    Pfeifer, D.
    Philipp, U.
    Duyster, J.
    Bertz, H.
    Finke, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 57 - 57
  • [6] Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children
    Thomas Pincez
    Raoul Santiago
    Henrique Bittencourt
    Isabelle Louis
    Mélanie Bilodeau
    Alexandre Rouette
    Loubna Jouan
    Josette-Renée Landry
    Françoise Couture
    Johanne Richer
    Pierre Teira
    Michel Duval
    Sonia Cellot
    Bone Marrow Transplantation, 2021, 56 : 2981 - 2989
  • [7] Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children
    Pincez, Thomas
    Santiago, Raoul
    Bittencourt, Henrique
    Louis, Isabelle
    Bilodeau, Melanie
    Rouette, Alexandre
    Jouan, Loubna
    Landry, Josette-Renee
    Couture, Francoise
    Richer, Johanne
    Teira, Pierre
    Duval, Michel
    Cellot, Sonia
    BONE MARROW TRANSPLANTATION, 2021, 56 (12) : 2981 - 2989
  • [8] Non-invasive Monitoring of Minimal Residual Disease and graft- versus-host Disease By Circulating cell-free Nucleic Acids after Allogeneic Hematopoietic Cell Transplantation
    Waterhouse, Miguel
    Pennisi, Sandra Patricia
    Pfeifer, Dietmar
    Duyster, Justus
    Bertz, Hartmut
    Finke, Juergen
    Duque-Afonso, Jesus
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 538 - 539
  • [9] Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation
    Kanaan, Sami B.
    Urselli, Francesca
    Radich, Jerald P.
    Nelson, J. Lee
    BLOOD ADVANCES, 2023, 7 (20) : 6066 - 6079
  • [10] circulating cell-free DNA (CFDNA) after allogeneic cell transplantation: Characteristics and clinical applications
    Waterhouse, Miguel
    Duque-Afonso, Jesus
    Pfeifer, Dietmar
    Duyster, Justus
    Bertz, Hartmut
    Finke, Juergen
    BONE MARROW TRANSPLANTATION, 2019, 54 : 481 - 482